Key Updates on the Sunshine Act Reporting Requirements You Need to Know
Staying compliant and accurately reporting all applicable payments and transfers of value to CMS under the Open Payments Program is more important than ever. As the DOJ continues its vigorous enforcement against pharmaceutical and device manufacturers and health care providers, the enforcement tool chest has expanded to include violations of the Open Payments Program.
Additionally, the scope of the Open Payments Program will expand next year to include more health care providers, further increasing enforcement risk. Join Dinsmore attorney Sarah diFrancesca as she discusses key developments in Sunshine Act reporting and provides in-depth analysis of the impact and legal precautions life sciences and health care professionals and entities should take to ensure they remain compliant.